Postmenopausal Osteoporosis is an Age Related Physiological Change and not A Disease by Hadapad, Basavaraj S
Published online in http://ijam. co. in 
276 
International Journal of Ayurvedic Medicine, 2015, 6(4), 276-279 
ISSN: 0976-5921 
*Corresponding Author: 
Basavaraj S Hadapad 
Associate Professor of Ayurveda 
Kasturba Medical College,  
Manipal University, 
Manipal-576104, Karnataka, India   
Email address: drbasavarajh@hotmail.com / basava-
raj.h@manipal.edu 
Phone number: 09448547794   
Postmenopausal Osteoporosis is an Age Related Physiological Change and not A Disease 
 
Review Article 
 
 Basavaraj S Hadapad1*  
 
1. Associate Professor of Ayurveda, Kasturba Medical College,  
Manipal University, Manipal-576104, Karnataka, India   
 
Abstract  
 
 For the past few decades it is taught at medical schools that hormonal and calcium deficiencies are the main 
culprit in causation of Postmenopausal Osteoporosis.  Because of this myth, hormone replacement therapy (HRT) 
has been used increasingly to prevent and cure PMO by the medical graduates at global level. The very definition of 
“normality” is flawed seriously. The statistical mean plus/minus two standard deviations automatically brings in five 
per cent of normal people into the fold of patients-the false positives. This goes up to 25% when disease statistics 
are used to measure healthy people. If we extend this definition further, almost all will come under the umbrella of 
patients! Age related osteoporosis falls under this label.  
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Introduction  
A renowned American professor of medicine, 
Leon Eisenberg, with thirty five years of practical 
experience in her field, asks a fresh intern in her firm 
two important questions and surprisingly gets answers 
that baffle her! The first of it being “When does a 
healthy individual become a patient?” and the intern 
answers: “after consulting a physician”. Second 
question being “when does a patient become healthy 
individual? The answer was “rarely ever, if ever”. Hi-
tech modern medicine follows the linear laws in a non-
linear dynamic human system. Doctors have been 
predicting the unpredictable future of their patients for 
a long time in this system. The very definition of 
“normality” is flawed seriously. The statistical mean 
plus/minus two standard deviations automatically 
brings in five per cent of normal people into the fold of 
patients-the false positives. This goes up to 25% when 
disease statistics are used to measure healthy people. If 
we extend this definition further, almost all will come 
under the umbrella of patients! Age related osteoporosis 
falls under this label. 
Osteoporosis [Osteo-bone (Asthi), Poros-holes 
(Soushirya- Sarandratwam), Osis-condition] is the most 
common metabolic bone disease which is defined as 
reduction of bone mass (or density) or the presence of a 
fragility fracture. The reduction in bone tissue is 
accompanied by deterioration in the architecture of the 
skeleton, leading to markedly increased risk of fracture. 
In 1994 a World Health organization study group 
recommended a clinical definition of osteoporosis 
based on bone mineral density (BMD) measurements 
expressed in standard deviation (SD) units called T- 
scores which are calculated by taking the difference 
between a patient’s measured BMD and the mean BMD 
of healthy young adults matched for gender and ethnic 
group and expressing the difference relative to the 
young adult population SD.  
          There is some space for a doubt to consider this 
clinical definition of osteoporosis for postmenopausal 
women because decrease in bone density is a universal 
feature of ageing. How then could one compare their 
bone mass density with that of young healthy adults?  
Similarly then grey hair will be a disease compared to 
the young dark hair.  How ever now days, irrespective 
of age related changes in the bone remodeling process a 
patient with T- score less than – 2.5 at spine, hip or 
forearm is diagnosed with postmenopausal osteoporosis. 
Routine screening of apparently healthy people could 
seriously damage their health says an editorial in a 
recent issue of the British Medical Journal (1). This 
brings to my mind saying of Mark Twain which goes 
thus: “For a man with a hammer in the hand, and 
wanting to use it badly, everything in the world looks a 
nail needing hammering.”  
          Epidemiological studies in the United States of 
America have estimated that more than one million 
Americans experience a significant fragility fracture 
each year at a cost of over $ 14 billion and in the United 
Kingdom osteoporotic fractures occur in 150,000 
individuals annually at a cost of over £750 million.         
High incidence of PMO could be because of “disease 
mongering” by the pharmaceutical industries, disease 
mongering medicalises human life turning ordinary 
ailments into medical problems, seeing mild symptoms 
as serious, treating personal problems as medical, 
seeing risks as diseases , and framing prevalence 
estimates to maximize potential market(2).  They see 
what they want to see in their research (3)! 
          From physiological point of view, once peak 
skeletal mass is attained, the process of remodeling 
becomes the principle metabolic activity of the skeleton. 
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This process has three primary functions: to repair 
micro damage within the skeleton, to maintain skeletal 
strength and, to supply calcium from the skeleton to 
maintain serum calcium. Bone remodeling is regulated 
by several circulating hormones, including estrogens, 
androgens, vitamin D, and PTH, as well as locally 
produced growth factors such as IGF-1and2, TGF, 
PTHrP, prostaglandins, TNF. Additional influences 
include nutrition, physical activity, genetic influences, 
race etc. The end result of this bone remodeling process 
(BRP) is that the resorbed bone is replaced by an equal 
amount of new bone tissue. After age 30 to 45, the 
resorption and formation process become imbalanced, 
and RESORPTION EXCEEDS FORMATION which 
can be taken as increased catabolic asthidhatwagni in 
Ayurveda.  
          PMO results from, bone loss due to normal age 
related changes which is swabhavika (4,5) in bone 
remodeling. Now it is very clear that PMO is age 
related, and diagnosis of a disease there needs the 
comparison with those age group normals and not with 
young adults bone density score (6).  Many times in 
these elderly women there is no deficiency of serum 
calcium either (7). About 20% of postmenopausal 
women with osteoporosis have hyper-calciurea, here 
hormone deficiency is not the only culprit, but 
resorption rate is higher than formation, so physician 
should think about increased resorption not about 
formation rate by giving calcium supplements etc.   
          But over the past few decades it is taught at 
medical schools that hormonal and calcium deficiencies 
are the main causes.  Because of this preaching, 
hormone replacement therapy (HRT) has been used 
increasingly to prevent and cure PMO and other chronic 
diseases by the medical graduates at global level. But 
based on pathophysiology of PMO there are no 
scientific convincing clinical evidences to use HRT and 
calcium. This view is supported by recent conclusion of 
many clinical trials of HRT that is “do not use 
estrogen / progesterone to prevent chronic diseases” 
including PMO, risks are higher than benefits; those 
being ovarian cancer, breast cancer, stroke, pulmonary 
embolism, coronary heart disease etc (8,9). Present day 
management of PMO brings to my mind a saying of Nin 
Anais: “We do not see things as they are; we see them 
as we are”  
          Looking at clinical features of PMO, most 
individuals diagnosed on the basis of bone densitometry 
are asymptomatic; many patients with quite advanced 
osteoporosis remain asymptomatic until a fracture 
occurs, because low bone density alone does not cause 
any symptoms, osteoporotic fractures, lifting a heavy 
weight precipitates pain in the vertebral fracture. The 
clinical presentation of vertebral fracture is highly 
variable, in some cases the onset is sudden with acute 
back pain, where as in others the presentation is 
insidious with gradual loss of height and chronic back 
pain, the pain of osteoporotic fracture often radiates 
anteriorly with nerve root distribution and may be made 
worse by back movement. 
 Asymptomatic postmenopausal women are 
treated with HRT without knowing through what 
mechanism hormones act (10) for prevention and cure 
of chronic diseases including osteoporosis and 
osteoporotic fractures based on very poor evidence of 
benefits. Use of HRT has increased among 
postmenopausal women in western countries. As 
estimated 20 million women worldwide were using it in 
the late 1990’s (11).  
 JAMA of July, 2002-VOL 288, No. 3, 321-333 
had good news for asymptomatic postmenopausal 
women but bad news for medi-business that overall 
health risks of hormone replacement outweighs the 
good effects. Many other clinical trials also echoed the 
same sentiments. All the killer diseases that HRT was 
supposed to prevent are in fact brought on by HRT
(12,13, 9,14,15,16,17,18,19,20,21)!  
 As long as women are asymptomatic it is better 
not to predict unpredictable things and interfere with 
HRT. Sir William Osler, a great brain in modern 
medicine had warned years ago: “patient doing well-do 
not interfere.” One example is a study on insulin 
therapy on diabetics, only symptomatic patients got 
benefits but asymptomatic patients did not get any 
benefits (22). But proper traditional diet, lifestyle and 
seasonal purification procedures which are essential 
part of life can be followed for healthy a life.  
          Ayurvedic texts do not explain asymptomatic 
diseases and their management. Acharya’s have 
explained kriyakala (different stages of disease 
manifestation) with chikitsa (treatment) to check 
progress of the samprapti (pathogenesis) but not for 
asymptomatic disease. 
Ayurvedic diagnosis of PMO is also not possible 
until and unless there occurs a fracture. The question of 
management does not therefore arise. The osteoporotic 
changes detected by DEXA can be diagnosed as 
Asthisoushirya.  Arunadatta and Hemadri commenting 
on symptoms caused by aggravated vata dosha(23) 
opine that Asthisoushirya means Asthi (Bone) and 
Soushirya (with pores). Comparison of PMO with 
Asthigata vata does not hold well because the latter is 
characterized by “Bhedho asthiparvanam, 
sandhishoolam, mamsabala kshayam, aswapnah 
santataruk cha (24)”   
Asthi Soushirya is swabhavika (age related 
changes etc) so curative approach by any system of 
health delivery may not be acceptable and successful 
(Swabhavo Nispratikriaya – natural changes can not be 
treated) but surely the rate of resorption can be slowed 
down by diet, life style changes and exercise according 
to dinacharya (daily regimen), rutucharya (seasonal 
regimen), and asthi pradoshaja chikitsa that is basti in 
grishma rutu. The principles and efficacy of Indian 
system of medicine are demonstrated truth established 
after several examinations and reasoning thousands of 
years ago which is known as Siddhant (25). 
All women, irrespective of race and nationality, 
attain menopause and have deficiency of hormones but 
incidence of PMO is high in western countries 
compared to ours. There could be many reasons-
increased salt intake in the preserved food is a very 
important reason in addition to the weather, smoking, 
alcohol, contraceptives, refined oils etc (26). Indian 
foods, in moderation, could be having some preventive 
effect (27).  
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If postmenopausal women have signs and symptoms of 
Asthi kshaya, Asthi pradoshaja chikitsa may be 
adopted. “Bastaya Ksheera Sarpishi tiktakopahitani 
cha”(28)  snehapana and ksheera basti with Panchatikta 
Guggulaghrata, Mahatiktaghrata, Patoladighrata, 
Panchatiktaghrata, Tiktaka ghrata etc can be tried to 
slow down the process of Asthikshaya. 
 
Conclusion  
 Estrogen deficiency is not the only culprit in 
postmenopausal osteoporosis. The latter is definitely 
age related. For diagnosis of asthisuoshirya bone 
densitometry test is must. Curative approach for an age 
related disease by any system of medicine looks 
preposterous, but the rate of resorption can be slowed 
down by diet and lifestyle. (dinacharya,  rutucharya and, 
by basti in every grishma rutu as explained in Asthi 
Pradoshaja Chikitsa) 
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